Role of different Juices in the Management of Osteoarthritis, Rheumatoid Arthritis and Backache - A Review

Skeletal system is a very important system of living body. If any malformation occurs it leads to severe problems which are highly intolerable by an individual. Some of the diseases comes under this are osteoarthritis, rheumatoid arthritis, backache, etc. Management of such diseases is now based on diagnosis, but still it is complicated to treat and associated causes are difficult to find out in many cases. Mainly diet plays a major and important role in prevention of skeletal disorders, under diet regimen different combination of fruit and vegetable juices plays a vital role in management of diseases. Modification in combination of juices and knowledge of their chemical constituent helps in management of skeletal disorder. Due to deficiency of mineral, vitamin or other necessary component is find out, we can use the natural supplement in the form of juices which are rich in minerals, vitamins and get easily digest and minimize the risk of the disease and provide soothing results. Juices of spinach, broccoli, apple, parsley, cherry, blueberry, ginger root, carrot, lettuce, kale, turnip, etc. plays an important role in management of different types of skeletal disorders. By proper knowledge of chemical constituent of fruits and vegetable we may minimize the risk of diseases associated with skeletal system and helps the sufferer up to a better extent

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Background Findings from the RESTART trial suggest that starting antiplatelet therapy might reduce the risk of recurrent symptomatic intracerebral haemorrhage compared with avoiding antiplatelet therapy. Brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases (such as cerebral microbleeds) are associated with greater risks of recurrent intracerebral haemorrhage. We did subgroup analyses of the RESTART trial to explore whether these brain imaging features modify the effects of antiplatelet therapy

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Background: Antiplatelet therapy reduces the risk of major vascular events for people with occlusive vascular disease, although it might increase the risk of intracranial haemorrhage. Patients surviving the commonest subtype of intracranial haemorrhage, intracerebral haemorrhage, are at risk of both haemorrhagic and occlusive vascular events, but whether antiplatelet therapy can be used safely is unclear. We aimed to estimate the relative and absolute effects of antiplatelet therapy on recurrent intracerebral haemorrhage and whether this risk might exceed any reduction of occlusive vascular events. Methods: The REstart or STop Antithrombotics Randomised Trial (RESTART) was a prospective, randomised, open-label, blinded endpoint, parallel-group trial at 122 hospitals in the UK. We recruited adults (≥18 years) who were taking antithrombotic (antiplatelet or anticoagulant) therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage, discontinued antithrombotic therapy, and survived for 24 h. Computerised randomisation incorporating minimisation allocated participants (1:1) to start or avoid antiplatelet therapy. We followed participants for the primary outcome (recurrent symptomatic intracerebral haemorrhage) for up to 5 years. We analysed data from all randomised participants using Cox proportional hazards regression, adjusted for minimisation covariates. This trial is registered with ISRCTN (number ISRCTN71907627). Findings: Between May 22, 2013, and May 31, 2018, 537 participants were recruited a median of 76 days (IQR 29–146) after intracerebral haemorrhage onset: 268 were assigned to start and 269 (one withdrew) to avoid antiplatelet therapy. Participants were followed for a median of 2·0 years (IQR [1·0– 3·0]; completeness 99·3%). 12 (4%) of 268 participants allocated to antiplatelet therapy had recurrence of intracerebral haemorrhage compared with 23 (9%) of 268 participants allocated to avoid antiplatelet therapy (adjusted hazard ratio 0·51 [95% CI 0·25–1·03]; p=0·060). 18 (7%) participants allocated to antiplatelet therapy experienced major haemorrhagic events compared with 25 (9%) participants allocated to avoid antiplatelet therapy (0·71 [0·39–1·30]; p=0·27), and 39 [15%] participants allocated to antiplatelet therapy had major occlusive vascular events compared with 38 [14%] allocated to avoid antiplatelet therapy (1·02 [0·65–1·60]; p=0·92). Interpretation: These results exclude all but a very modest increase in the risk of recurrent intracerebral haemorrhage with antiplatelet therapy for patients on antithrombotic therapy for the prevention of occlusive vascular disease when they developed intracerebral haemorrhage. The risk of recurrent intracerebral haemorrhage is probably too small to exceed the established benefits of antiplatelet therapy for secondary prevention

Hesitant probabilistic fuzzy linguistic sets with applications in multi-criteria group decision making problems

Uncertainties due to randomness and fuzziness comprehensively exist in control and decision support system. In the present study, we introduce notion of occurring probability of possible values into hesitant fuzzy linguistic element (HFLE) and define hesitant probabilistic fuzzy linguistic set (HPFLS) for ill structured and complex decision making problem. HPFLS provides single framework where both stochastic and non-stochastic uncertainties can be efficiently handled along with hesitation. We have also proposed expected mean, variance, score and accuracy function and basic operations for HPFLS. Weighted and ordered weighted aggregation operators for HPFLS are also defined in the present study for its applications in multi-criteria group decision making (MCGDM) problems. We propose a MCGDM method with HPFL information which is illustrated by an example. A real case study is also taken in the present study to rank State Bank of India, InfoTech Enterprises, I.T.C., H.D.F.C. Bank, Tata Steel, Tata Motors and Bajaj Finance using real data. Proposed HPFLS based MCGDM method is also compared with two HFL based decision making methods

Multi-hazard risk assessment of rail infrastructure in India under local vulnerabilities towards adaptive pathways for disaster resilient infrastructure planning

“Lifeline of the nation” is the motto of Indian Railways as it connects through a common thread, billion plus population in one way or the other. The National Rail Plan for India – 2030 focuses on creating a ‘future ready’ Railway system by 2030 by suitably integrating new railway systems like high-speed rails. However, rail infrastructure is exposed to multi-hazards and disasters sometimes disrupt safe rail operations. This study explores rail infrastructure risk assessment at a national scale utilizing the UNDRR framework and synthesized application of geospatial technologies with a focus on disentanglement of local vulnerabilities of the rail infrastructure assets utilizing factors of health of bridges, visibility obstruction to level crossings, labour wages & their regions and GSDP under multi-hazard scenarios. The results revealed that the NR and NFR were identified as high-risk routes under the risk analysis of physical and social vulnerability scenarios, followed by CR Railways. The average annual frequencies of emergency cases in each zone show a correlation r (17) = 0.4758 with the combined mean risk ranks for each zone. In comparison to socioeconomic factors, which contribute to indirect losses, physical factors directly affect safety and contribute to direct losses. Further, outcomes depict more accidents on Indian Railways during the monsoon (nearly 50%) and cold weather (29%) seasons. The study suggests that with the participation of key stakeholders, including urban and transport planners, an integrated approach is helpful in identifying critical rail routes towards risk-informed adaptive disaster-resilient infrastructure planning for providing safety, continuity and reliability of essential rail services

Observation of structural change-driven Griffiths to non-Griffiths-like phase transformation in Pr2-xSrxCoFeO6 (x= 0 to 1)

The study of crystal structure, electronic structure, transport, and magnetic properties of heterovalent Sr2+ doped Pr2-xSrxCoFeO6 (x = 0.0 to 1.0) system have been done. Crystal structure study reveals an occurrence of structural change from orthorhombic (Pnma) to tetragonal (I4/m) phase above x = 0.6. A sudden transformation of the Griffiths-like to non-Griffiths-like magnetic phase is observed as the system changes its crystal structure from Pnma to I4/m. The X-ray photoemission spectroscopy (XPS) study suggests for the existence of mixed oxidation states of the B-site ions viz., Co3+/Co4+ and Fe3+/Fe4+, and it also indicates an increase in the mean oxidation states owing to the hole substitution (Sr2+). The temperature variation of the electrical resistivity of the studied systems follows two different transport mechanisms, such as the variable range hopping (VRH) (in the lower temperature region) and small polaron hoping (SPH) (in the higher temperature region) models. Dc magnetization study shows that a local competing ferromagnetic (FM) exchange interaction increases with Sr doping. Finally, the ac susceptibility study reveals breaking of the long-range-ordering in the system x = 1.0, which appears to be related to the structural change and enhanced spin frustration due to increased competing local FM exchange interactions. In addition, electronic density of states (DOS) calculations of PrSrCoFeO6 (i.e. x = 1.0) using the density functional theory (DFT) have been performed for various Co/Fe atomic distributions. For most of the Co/Fe atomic distributions studied, the calculations show that the total energy of the system with FM coupling among spins has slightly lower energy than that for antiferromagnetic (AFM) coupling

Book of Abstracts of the 2nd International Conference on Applied Mathematics and Computational Sciences (ICAMCS-2022)

It is a great privilege for us to present the abstract book of ICAMCS-2022 to the authors and the delegates of the event. We hope that you will find it useful, valuable, aspiring, and inspiring. This book is a record of abstracts of the keynote talks, invited talks, and papers presented by the participants, which indicates the progress and state of development in research at the time of writing the research article. It is an invaluable asset to all researchers. The book provides a permanent record of this asset. Conference Title: 2nd International Conference on Applied Mathematics and Computational SciencesConference Acronym: ICAMCS-2022Conference Date: 12-14 October 2022Conference Organizers: DIT University, Dehradun, IndiaConference Mode: Online (Virtual